<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT933-1469</title>
	</head>
	<body>
		<main>
			<p>930923 FT  23 SEP 93 / London Stock Exchange: BOC downgrade A cut in profits forecasts by a UK securities house for BOC Group led to weakness in the share price, which receded 6 to 636p. Smith New Court reduced profits expectation to Pounds 335m from Pounds 340m for the current year and by Pounds 15m to a flat Pounds 335m for next year after receiving the latest US sales figures for Forane, BOC's anaesthetic gas which came off patent at the start of the year. The figures showed July sales were down 58 per cent from the previous year. Mr Philip Morrish of Smith said: 'BOC's hopes of holding on to 50 per cent market share in the US are pie in the sky.'</p>
		</main>
</body></html>
            